Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 3/20 | 0.35 |
| ▸ | RAB9A | P51151 | 3/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 1/20 | 0.32 |
| ▸ | MC4R | P32245 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.32 |
| ▸ | NAAA | Q02083 | 1/20 | 0.32 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.32 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4136748 | 0.90 | TSHR (0.34) | NPC1RAB9ASMN1; SMN2HTR2CALDH1A1 | |
| SCHEMBL5330841 | 0.83 | TSHR (0.40) | NPC1RAB9AEPHX2HTR2CMC4R | |
| SCHEMBL4694770 | 0.78 | NPC1 (0.35) | NPC1RAB9AEPHX2HTR2CMC4R | |
| SCHEMBL4695714 | 0.78 | NPC1 (0.33) | NPC1RAB9AEPHX2HTR2CMC4R | |
| SCHEMBL4695715 | 0.78 | NPC1 (0.33) | NPC1RAB9AEPHX2HTR2CMC4R | |
| SCHEMBL4697074 | 0.76 | NPC1 (0.34) | NPC1RAB9AEPHX2SMN1; SMN2ALDH1A1 | |
| SCHEMBL5187221 | 0.75 | NPC1 (0.37) | NPC1RAB9AEPHX2SMN1; SMN2HTR2C | |
| SCHEMBL4693843 | 0.73 | KEAP1 (0.40) | NPC1RAB9AALDH1A1 | |
| SCHEMBL5252045 | 0.73 | EPHX2 (0.34) | NPC1RAB9AEPHX2SMN1; SMN2HTR2C | |
| SCHEMBL5258725 | 0.73 | EPHX2 (0.34) | NPC1RAB9AEPHX2SMN1; SMN2HTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1569935-B1 | HETEROCYCLIC COMPOUNDS, PREPARATION METHOD THEREOF AND USE OF SAME AS MEDICAMENTS, SUCH AS ANTI-BACTERIAL MEDICAMENTS AND BETA-LACTAMASE INHIBITORS | NOVEXEL (FR) | 2008-08-20 | — | — | EP | disclosed |
| EP-1798231-A2 | Intermediate products for the preparation of antibacterial compounds | NOVEXEL (FR) | 2007-06-20 | — | — | EP | disclosed |
| EP-1399444-B1 | NOVEL HETEROCYCLIC COMPOUNDS, METHOD FOR PREPARING SAME AND USE THEREOF AS MEDICINES, IN PARTICULAR AS ANTI-BACTERIAL AGENTS | NOVEXEL (FR) | 2007-04-11 | — | — | EP | disclosed |